title: Mitral valve prolapse: old beliefs yield to new knowledge.
abstract: Much of the conventional wisdom about the prevalance, causes, diagnosis, symptoms, effects, and treament of mitral valve prolapse (MVP) is changing. MVP has a benign course and excellent prognosis for most patients, with only a small minority developing serious complications.
authors.affiliation: Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Ohio 44195, USA.
authors.forename: Emil
authors.initials: E
authors.lastname: Hayek
authors.forename: Brian
authors.initials: B
authors.lastname: Griffin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology; D001241:Aspirin / Q000627:therapeutic use; D016757:Death, Sudden, Cardiac / Q000209:etiology; D004697:Endocarditis, Bacterial / Q000209:etiology; D005260:Female; D006801:Humans; D008943:Mitral Valve / Q000002:abnormalities; D008944:Mitral Valve Insufficiency / Q000209:etiology; D008945:Mitral Valve Prolapse / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D020521:Stroke / Q000209:etiology
chemical_list: D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D001241:Aspirin